BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CHARM-EU - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://charm-eu.eu
X-WR-CALDESC:Events for CHARM-EU
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251103
DTEND;VALUE=DATE:20251105
DTSTAMP:20260610T033603
CREATED:20251030T145548Z
LAST-MODIFIED:20251030T145548Z
UID:10000110-1762128000-1762300799@charm-eu.eu
SUMMARY:Democracy4All conference explores the impact of artificial intelligence on democracy
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/democracy4all-conference-explores-the-impact-of-artificial-intelligence-on-democracy/
CATEGORIES:Governance,Innovation,Planetary Health
ATTACH;FMTTYPE=image/jpeg:https://charm-eu.eu/wp-content/uploads/2025/10/creativitatdemocracy4all-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251112
DTEND;VALUE=DATE:20251113
DTSTAMP:20260610T033604
CREATED:20250624T081308Z
LAST-MODIFIED:20251110T144827Z
UID:10000091-1762905600-1762991999@charm-eu.eu
SUMMARY:CHARM-EU Annual Conference 2025
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-annual-conference-2025/
LOCATION:Bar Beton\, Pythagoraslaan 101\, Utrecht\, Netherlands
CATEGORIES:Sustainability
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/06/SQUARE-POST-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251124T130000
DTEND;TZID=Europe/Paris:20251124T140000
DTSTAMP:20260610T033604
CREATED:20251028T090010Z
LAST-MODIFIED:20251028T154244Z
UID:10000104-1763989200-1763992800@charm-eu.eu
SUMMARY:CHARM ON #3: Citizen Science in Action
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-on-3-citizen-science-in-action/
CATEGORIES:CHARM-EU event,Interculturality,Learning,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251127T083000
DTEND;TZID=Europe/Paris:20251127T173000
DTSTAMP:20260610T033604
CREATED:20251110T152023Z
LAST-MODIFIED:20251110T152028Z
UID:10000111-1764232200-1764264600@charm-eu.eu
SUMMARY:Closing event of the Planetary Health Joint Master’s Programme
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/closing-event-of-the-planetary-health-joint-masters-programme/
LOCATION:ELTE Faculty of Science\, 1117 Budapest Pázmány Péter sétány 1/A\, Budapest\, Hungary
CATEGORIES:Learning,Planetary Health
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251215T110000
DTEND;TZID=Europe/Paris:20251215T120000
DTSTAMP:20260610T033604
CREATED:20251204T071220Z
LAST-MODIFIED:20260106T165013Z
UID:10000112-1765796400-1765800000@charm-eu.eu
SUMMARY:Enacting Education for Sustainable Development: spotlight on teaching practices for exploring ‘Worldviews\, Perceptions and Values’.
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/enacting-education-for-sustainable-development-spotlight-on-teaching-practices-for-exploring-worldviews-perceptions-and-values/
LOCATION:online
CATEGORIES:CHARM-EU event,Interculturality,Learning,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260119T110000
DTEND;TZID=Europe/Paris:20260119T120000
DTSTAMP:20260610T033604
CREATED:20260106T164425Z
LAST-MODIFIED:20260108T145031Z
UID:10000118-1768820400-1768824000@charm-eu.eu
SUMMARY:Enacting Education for Sustainable Development 2: spotlight on teaching practices for exploring ‘Worldviews\, Perceptions and Values’.
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/enacting-education-for-sustainable-development-2/
LOCATION:online
CATEGORIES:CHARM-EU event,Learning,Sustainability,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260121T110000
DTEND;TZID=Europe/Paris:20260121T130000
DTSTAMP:20260610T033604
CREATED:20260105T102505Z
LAST-MODIFIED:20260109T131036Z
UID:10000116-1768993200-1769000400@charm-eu.eu
SUMMARY:Master's in Global Challenges for Sustainability Hybrid Open Day at ELTE\, Budapest\, Hungary
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/masters-in-global-challenges-for-sustainability-open-day-at-elte-budapest-hungary/
CATEGORIES:CHARM event,CHARM-EU event,Learning
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/12/charmeu-masters2026-socialmedia-banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20260121T123000
DTEND;TZID=Europe/Helsinki:20260121T140000
DTSTAMP:20260610T033604
CREATED:20251219T104351Z
LAST-MODIFIED:20251219T104437Z
UID:10000114-1768998600-1769004000@charm-eu.eu
SUMMARY:Presentation of the Master's in Global Challenges for Sustainability\, in Turku\, Finland
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/presentation-of-the-masters-in-global-challenges-for-sustainability-in-turku-finland/
LOCATION:Åbo Akademi University\, Tuomiokirkontori 3\, Turku\, 20500\, Finland
CATEGORIES:CHARM event,CHARM-EU event,Learning
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/12/charmeu-masters2026-socialmedia-banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260122
DTEND;VALUE=DATE:20260124
DTSTAMP:20260610T033604
CREATED:20260116T093243Z
LAST-MODIFIED:20260121T145318Z
UID:10000124-1769040000-1769212799@charm-eu.eu
SUMMARY:The Polyglot League networking event
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/the-polyglote-league-networking-event/
LOCATION:Edifici Històric\, Universitat de Barcelona\, Pl. de la Universitat\, L'Eixample\, Barcelona\, Catalunya\, 08007\, Spain
CATEGORIES:CHARM event,Inter-Institutional Working Groups,Interculturality,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260126T130000
DTEND;TZID=Europe/Paris:20260126T140000
DTSTAMP:20260610T033604
CREATED:20260106T153139Z
LAST-MODIFIED:20260122T145914Z
UID:10000117-1769432400-1769436000@charm-eu.eu
SUMMARY:CHARM ON #4: Speaking Across Borders: Language and Intercultural Communication
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm_on_4_speaking_across_borders/
LOCATION:online
CATEGORIES:CHARM-EU event,Interculturality,Learning,Teaching
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2026/01/charm-on-banner-e1767713475537.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260127
DTEND;VALUE=DATE:20260129
DTSTAMP:20260610T033604
CREATED:20260114T101700Z
LAST-MODIFIED:20260128T082459Z
UID:10000121-1769472000-1769644799@charm-eu.eu
SUMMARY:Grand Finale 2026
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/grand-finale-2026/
LOCATION:FIMA\, Faculty of Information and Audiovisual Media\, Melcior de Palau\, 140\, Barcelona\, Barcelona\, 08014\, Spain
CATEGORIES:CHARM event,Learning,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260129T110000
DTEND;TZID=Europe/Paris:20260129T120000
DTSTAMP:20260610T033604
CREATED:20260114T130916Z
LAST-MODIFIED:20260127T142658Z
UID:10000123-1769684400-1769688000@charm-eu.eu
SUMMARY:Commencement Ceremony 4th cohort - Master's programme is Global Challenges for Sustainability
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/commencement-ceremony-4th-cohort-masters-programme-is-global-challenges-for-sustainability/
LOCATION:Edifici Històric\, Universitat de Barcelona\, Pl. de la Universitat\, L'Eixample\, Barcelona\, Catalunya\, 08007\, Spain
CATEGORIES:CHARM event,Learning,Sustainability,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260129T120000
DTEND;TZID=Europe/Paris:20260129T140000
DTSTAMP:20260610T033604
CREATED:20251215T141411Z
LAST-MODIFIED:20251215T141638Z
UID:10000113-1769688000-1769695200@charm-eu.eu
SUMMARY:New Hybrid Classroom at JMU: Perspectives\, Practices\, and Solutions 
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/new-hybrid-classroom-at-jmu-perspectives-practices-and-solutions/
LOCATION:Würzburg University\, Emil-Fischer-Straße 70\, Gebäude 70\, 97074\, Würzburg\, Germany
CATEGORIES:CHARM event,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260129T130000
DTEND;TZID=UTC:20260129T140000
DTSTAMP:20260610T033604
CREATED:20260122T152108Z
LAST-MODIFIED:20260122T152756Z
UID:10000126-1769691600-1769695200@charm-eu.eu
SUMMARY:CHARM-EU Open Day at Trinity College Dublin
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-open-day-at-trinity-college-dublin/
LOCATION:Naughton Institute\, Trinity College Dublin\, D02 W9K7\, Naughton Institute\, Trinity College Dublin\, Dublin\, Dublin\, D02 W9K7\, Ireland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260130
DTEND;VALUE=DATE:20260131
DTSTAMP:20260610T033604
CREATED:20251219T105144Z
LAST-MODIFIED:20251219T105402Z
UID:10000115-1769731200-1769817599@charm-eu.eu
SUMMARY:Presentation of the Master's in Global Challenges for Sustainability\, in Utrecht\, The Netherlands
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/presentation-of-the-masters-in-global-challenges-for-sustainability-in-utrecht-netherlands/
LOCATION:Utrecht University\, Heidelberglaan 8\, Utrecht\, Netherlands
CATEGORIES:CHARM event,CHARM-EU event,Learning
ATTACH;FMTTYPE=image/png:https://charm-eu.eu/wp-content/uploads/2025/12/charmeu-masters2026-socialmedia-banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260204
DTEND;VALUE=DATE:20260207
DTSTAMP:20260610T033604
CREATED:20260202T093644Z
LAST-MODIFIED:20260202T102402Z
UID:10000128-1770163200-1770422399@charm-eu.eu
SUMMARY:CHARM-EU Winter School 2026
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-winter-school-2026/
LOCATION:University of Barcelona. Faculty of Economics and Business\, Diagonal\, 690-696\, Room 2019 (Building 696).\, Barcelona\, Barcelona\, 08034\, Spain
CATEGORIES:CHARM event,Innovation,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260204T090000
DTEND;TZID=Europe/Paris:20260205T120000
DTSTAMP:20260610T033604
CREATED:20260114T115112Z
LAST-MODIFIED:20260115T081417Z
UID:10000122-1770195600-1770292800@charm-eu.eu
SUMMARY:Legal Issues in Scientific Cooperation with China - Online Workshop
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/legal-issues-in-scientific-cooperation-with-china-online-workshop/
CATEGORIES:Interculturality,Research
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260212T130000
DTEND;TZID=Europe/Paris:20260212T170000
DTSTAMP:20260610T033604
CREATED:20260206T080251Z
LAST-MODIFIED:20260206T080400Z
UID:10000131-1770901200-1770915600@charm-eu.eu
SUMMARY:Online Presentation of ZHFE (Journal for Higher Education Development) Special Issue: “New Models of the University”
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/online-presentation-of-zhfe-journal-for-higher-education-development-special-issue-new-models-of-the-university/
CATEGORIES:Innovation,Inter-Institutional Working Groups
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260214
DTEND;VALUE=DATE:20260215
DTSTAMP:20260610T033604
CREATED:20260127T114738Z
LAST-MODIFIED:20260127T114738Z
UID:10000127-1771027200-1771113599@charm-eu.eu
SUMMARY:Presentation of the Master’s in Global Challenges for Sustainability\, in Montpellier\, France
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/presentation-of-the-masters-in-global-challenges-for-sustainability-in-montpellier-france/
LOCATION:Université de Montpelllier\, 163 rue Auguste Broussonnet\, Montpellier\, 34000\, France
CATEGORIES:CHARM-EU event,Learning
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260216T110000
DTEND;TZID=Europe/Paris:20260216T120000
DTSTAMP:20260610T033604
CREATED:20260203T154050Z
LAST-MODIFIED:20260204T135025Z
UID:10000130-1771239600-1771243200@charm-eu.eu
SUMMARY:Enacting Education for Sustainable Development 3: spotlight on teaching practices for exploring ‘Worldviews\, Perceptions and Values’
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/enacting-education-for-sustainable-development-3/
LOCATION:online
CATEGORIES:CHARM-EU event,Learning,Sustainability,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260223
DTEND;VALUE=DATE:20260228
DTSTAMP:20260610T033604
CREATED:20260122T133152Z
LAST-MODIFIED:20260122T133503Z
UID:10000125-1771804800-1772236799@charm-eu.eu
SUMMARY:Staff Week 3.0 ELTE\, Budapest (Erasmus+ BIP)
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/staff-week-3-0-elte-budapest-erasmus-bip/
LOCATION:ELTE Faculty of Law\, Egyetem tér 1–3.\, Budapest\, Hungary
CATEGORIES:Mobility
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260224T160000
DTEND;TZID=Europe/Paris:20260224T170000
DTSTAMP:20260610T033604
CREATED:20260203T143557Z
LAST-MODIFIED:20260211T142544Z
UID:10000129-1771948800-1771952400@charm-eu.eu
SUMMARY:CHARM-EU Innovators’ Journey: Sustainable Entrepreneurs\, and what their needs are
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-innovators-journey-unlocking-innovation-through-entrepreneurship-2/
LOCATION:HALC University of Utrecht\, Androclus building\, Room 0.004 Yalelaan 1\, Utrecht\, Utrecht\, 3584
CATEGORIES:CHARM event,Innovation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260304T140000
DTEND;TZID=Europe/Paris:20260304T170000
DTSTAMP:20260610T033604
CREATED:20260212T095021Z
LAST-MODIFIED:20260227T113317Z
UID:10000132-1772632800-1772643600@charm-eu.eu
SUMMARY:STOA high-level conference - Academic Freedom in Support of Democracy
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/stoa-high-level-conference-academic-freedom-in-support-of-democracy/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260318
DTEND;VALUE=DATE:20260320
DTSTAMP:20260610T033604
CREATED:20260309T144516Z
LAST-MODIFIED:20260309T152010Z
UID:10000135-1773792000-1773964799@charm-eu.eu
SUMMARY:CHARM-EU Professional Development Networking Days: Building Bridges for Academic Development and Educational Innovation
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-professional-development-networking-days-building-bridges-for-teacher-development-and-educational-innovation/
LOCATION:Ruhr West University of Applied Science\, Campus Parkstadt\, Wissollstraße 19\, Mülheim is an der Ruhr\, Mülheim is an der Ruhr\, 45478\, Germany
CATEGORIES:Innovation,Inter-Institutional Working Groups,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260320
DTEND;VALUE=DATE:20260410
DTSTAMP:20260610T033604
CREATED:20260305T084654Z
LAST-MODIFIED:20260316T122203Z
UID:10000134-1773964800-1775779199@charm-eu.eu
SUMMARY:CHARM-EU Ideathon 2026
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-eu-ideathon-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260416T160000
DTEND;TZID=Europe/Paris:20260416T180000
DTSTAMP:20260610T033604
CREATED:20260330T104816Z
LAST-MODIFIED:20260330T104816Z
UID:10000148-1776355200-1776362400@charm-eu.eu
SUMMARY:Why EDI Matters: Equ(al)ity\, Diversity and Inclusion in European Universities
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/why-edi-matters-equality-diversity-and-inclusion-in-european-universities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260420T130000
DTEND;TZID=Europe/Paris:20260420T140000
DTSTAMP:20260610T033604
CREATED:20260413T124348Z
LAST-MODIFIED:20260416T082915Z
UID:10000150-1776690000-1776693600@charm-eu.eu
SUMMARY:CHARM ON #6 - Breaking Boundaries: Transdisciplinarity in CHARM-EU
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/charm-on-6-breaking-boundaries-transdisciplinarity-in-charm-eu/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260424
DTSTAMP:20260610T033604
CREATED:20260310T134609Z
LAST-MODIFIED:20260408T103002Z
UID:10000138-1776902400-1776988799@charm-eu.eu
SUMMARY:Books for Sustainability
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/books-for-sustainability/
CATEGORIES:CHARM event,Sustainability
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260425
DTSTAMP:20260610T033604
CREATED:20260316T111517Z
LAST-MODIFIED:20260409T091139Z
UID:10000140-1776902400-1777075199@charm-eu.eu
SUMMARY:CHARM-EU Networking days: Building a European Network for « Sustainability Reporting » learning and research
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/building-a-european-network-for-sustainability-reporting-learning-and-research/
LOCATION:Richter University Libraries\, Espace Richter 60\, 1 Rue des États Généraux\, Montpellier\, Montpellier\, 34000\, France
CATEGORIES:Innovation,Inter-Institutional Working Groups,Teaching
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260427T090000
DTEND;TZID=Europe/Paris:20260427T133000
DTSTAMP:20260610T033604
CREATED:20260417T150456Z
LAST-MODIFIED:20260417T150456Z
UID:10000151-1777280400-1777296600@charm-eu.eu
SUMMARY:The future of the European Higher Education Framework 2028–2034 and the role of Erasmus+
DESCRIPTION:  \nOn September 24\, 2025\, an inaugural international conference on immunotherapies will launch in Montpellier (France) the 2025 edition of a CHARM-EU experimental interdisciplinary teaching module rooted in research.   \nFollowing the success of its first edition in 2024\, the experimental interdisciplinary teaching module “Tackling Health Challenges in Internationally Linked Research Hubs – Framing Solutions” is being renewed. Developed through a close collaboration between the University of Montpellier\, Utrecht University\, and SIRIC Montpellier Cancer\, the program has been broadened to welcome new partners in 2025: the University of Barcelona\, IHU Immun4cure\, and FHU Evocan-2.   \nOrganized within the framework of the Charm-EU alliance\, this experimental module is open to Master’s students from all countries and disciplines\, including medicine\, biology\, chemistry\, and biomedical engineering. It invites students to design innovative international research projects in cancer treatment\, working in small\, collaborative groups in a dynamic learning environment.  \nThe inaugural international conference “From Immune Activation to Toxicity: Challenges of Cancer Immunotherapies“ will take place on September 24\, 2025 in Montpellier (France). It will bring together clinicians\, researchers\, and patient associations to share their expertise with international students from diverse academic background. This event offers a unique opportunity for everyone involved in the field of immunotherapy research to meet\, exchange ideas\, and innovate together. Following the conference\, student teams will work throughout the academic year on developing research project proposals related to cancer pathologies\, supported by an international network of researchers committed to this topic.  \nThis programme has been designed in collaboration with the SIRIC Montpellier Cancer\, a site of excellence in cancer research accredited by the French National Cancer Institute (INCa)\, the IHU Immune4cure and the FHU Evocan-2\, for whose ambition is to develop new diagnostic and therapeutic concepts for cancer patients through an interdisciplinary approach. Several institutions on the site are involved\, in particular the Montpellier Cancer Institute (ICM) the Montpellier Cancer Research Institute (IRCM)\, the Montpellier Charles Gerhardt Institute (ICGM) and the Max Mousseron Biomolecules Institute (IBMM).univer  \nPractical Information:  \nProgram Highlights:  \nClinical Overview – Discussion on current clinical practices and challenges of Cancer Immunotherapies: From Immune Activation to Toxicity.  \nPatient Perspective – Insights from patients and patients’ associations on their experiences with cancer Immunotherapies.  Research Stakes Flash Presentations – Brief presentations on the latest research developments.  \nRound Table – From basics to real effects: an interactive session with experts to discuss key issues and future directions.  \nOnline EventThis is a hybrid international event. A connection link will be sent to registered participants prior to the conference.  \nLanguagesSimultaneous translation in French and English will be available.  \nDate & VenueSeptember 24\, 2025\, from 9:00 AM to 1:30 PMConference Room\, Montpellier Cancer Research Institute (IRCM)ICM Val d’Aurelle Campus\, 208 Avenue des Apothicaires\, Montpellier (France).   \n  \nRegister now: https://montpellier-cancer.com/charm-eu-research-hubs-from-immune-activation-to-toxicitychallenges-of-cancer-immunotherapies/  \n  \nContacts  \nSonia Cantel: sonia.cantel@umontpellier.fr  \nAurore Marquis: aurore.marquis@icm.unicancer.fr  \nGilles Subra: gilles.subra@umontpellier.fr  \nVanessa Vigano: vanessa.vigano@umontpellier.fr  \n  \n 
URL:https://charm-eu.eu/event/the-future-of-the-european-higher-education-framework-2028-2034-and-the-role-of-erasmus/
LOCATION:Pedralbes Palace Jordi Street Girona\, 22  08034 – Barcelona\, Pedralbes Palace Jordi Street Girona\, 22\, Barcelona\, 08034
CATEGORIES:Governance
END:VEVENT
END:VCALENDAR